DocGo Inc. (NASDAQ:DCGO) Receives Consensus Rating of “Hold” from Analysts

Shares of DocGo Inc. (NASDAQ:DCGO) have received a consensus rating of “Hold” from the six brokerages that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $2.3750.

A number of analysts recently weighed in on DCGO shares. Canaccord Genuity Group lowered their price target on shares of DocGo from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, March 25th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of DocGo in a report on Monday, May 11th. Wall Street Zen upgraded DocGo from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of DocGo in a research note on Thursday, June 18th.

DocGo Price Performance

Shares of NASDAQ DCGO opened at $0.65 on Monday. The firm’s 50-day simple moving average is $0.58 and its 200 day simple moving average is $0.67. The company has a market cap of $64.31 million, a price-to-earnings ratio of -0.34 and a beta of 1.02. DocGo has a 12-month low of $0.45 and a 12-month high of $1.78.

DocGo (NASDAQ:DCGO) last posted its quarterly earnings data on Monday, May 11th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.10). DocGo had a negative net margin of 62.23% and a negative return on equity of 44.09%. The company had revenue of $75.55 million during the quarter, compared to analyst estimates of $72.48 million. On average, equities analysts expect that DocGo will post -0.12 earnings per share for the current year.

Hedge Funds Weigh In On DocGo

Several hedge funds have recently added to or reduced their stakes in DCGO. Marquette Asset Management LLC acquired a new stake in DocGo in the second quarter worth about $175,000. Renaissance Technologies LLC lifted its position in DocGo by 167.1% during the 1st quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock valued at $950,000 after purchasing an additional 944,826 shares during the period. Isthmus Partners LLC boosted its stake in shares of DocGo by 14.0% in the 1st quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock valued at $637,000 after purchasing an additional 124,211 shares during the last quarter. Empowered Funds LLC boosted its stake in shares of DocGo by 14.6% in the 4th quarter. Empowered Funds LLC now owns 138,306 shares of the company’s stock valued at $121,000 after purchasing an additional 17,607 shares during the last quarter. Finally, Boothbay Fund Management LLC grew its position in shares of DocGo by 39.0% during the 4th quarter. Boothbay Fund Management LLC now owns 200,947 shares of the company’s stock worth $176,000 after buying an additional 56,413 shares during the period. Institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.